Canada markets closed

Venus Concept Inc. (VERO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.6831-0.0269 (-3.79%)
At close: 04:00PM EDT

Venus Concept Inc.

235 Yorkland Boulevard
Suite 900
Toronto, ON M2J 4Y8
Canada
877 848 8430
https://www.venus.ai

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees304

Key Executives

NameTitlePayExercisedYear Born
Dr. Hemanth Jacob Varghese CFA, Ph.D.President & COO582.67kN/A1976
Mr. Ross J. PortaroExecutive VP and GM of Global Sales & Marketing584.62kN/A1964
Mr. Rajiv Kanishka Liyanaarchchie De SilvaCEO & Director615.41kN/A1967
Mr. Domenic Della PennaExecutive VP & CFO396.8kN/A1962
Mr. Michael MandarelloGeneral Counsel & Corporate SecretaryN/AN/A1986
Mr. William H. McGrailExecutive Vice President of Technical Operations & ComplianceN/AN/A1961
Ms. Anat KotlerHead of Marketing & Product ManagementN/AN/A1984
Ms. Anna GeorgiadisChief Human Resources OfficerN/AN/A1971
Dr. Yoni IgerHead of Scientific & Clinical AffairsN/AN/A1960
Ms. Joyce MorrisHead of Sales - CanadaN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Corporate Governance

Venus Concept Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.